Order Article Reprints

Ikeda Y, Adachi K, Tomio K, Eguchi-Kojima S, Tsuruga T, Uchino-Mori M, Taguchi A, Komatsu A, Nagamatsu T, Oda K, et al. A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2). Vaccines. 2021; 9(4):329. https://doi.org/10.3390/vaccines9040329

Ikeda, Yuji, Katsuyuki Adachi, Kensuke Tomio, Satoko Eguchi-Kojima, Tetsushi Tsuruga, Mayuyo Uchino-Mori, Ayumi Taguchi, Atsushi Komatsu, Takeshi Nagamatsu, Katsutoshi Oda, and et al. 2021. "A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)" Vaccines 9, no. 4: 329. https://doi.org/10.3390/vaccines9040329

Ikeda, Y., Adachi, K., Tomio, K., Eguchi-Kojima, S., Tsuruga, T., Uchino-Mori, M., Taguchi, A., Komatsu, A., Nagamatsu, T., Oda, K., Kawana-Tachikawa, A., Uemura, Y., Igimi, S., Osuga, Y., Fujii, T., & Kawana, K. (2021). A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2). Vaccines, 9(4), 329. https://doi.org/10.3390/vaccines9040329